Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Nominee Sebelius Backs Imaging Reforms; On The Fence On Sunshine Bill

This article was originally published in The Gray Sheet

Executive Summary

Department of Health and Human Services Secretary-designee Kathleen Sebelius favors additional imaging payment reforms, but has not fully embraced the need for federal requirements for device and drug firms to report financial relationships with physicians

You may also be interested in...



NIH Dives Into Comparative Effectiveness Clash With Grant Opportunities

A 181-page grant application 1request from the National Institutes of Health has struck a nerve among congressional lawmakers debating the particulars of comparative-effectiveness research and comprehensive health reform

FDA Whistleblower Letter Released At Sebelius Confirmation Hearing

Nine FDA scientists urge "sweeping measures" and harsh disciplinary action within the agency in an April 2 1letter to President Obama that was publicly disclosed during a confirmation hearing for the likely next secretary of the Department of Health and Human Services

Obama Budget Seeks Prior Authorization For Medicare Imaging

President Obama's budget proposal for fiscal year 2010 includes a plan for Medicare to contract with private third parties to pre-review and approve imaging payments on a scan-by-scan basis

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027343

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel